Employer record no. 26175
Stemline Therapeutics, Inc.
US DOL LCA disclosure data, FY2022 to FY2026
Total LCA filings
12
Certified
10
Denied
0
FY2025 filings
3
Filings by fiscal year
* partial fiscal year; quarters still being published by DOL
Peer rank
#2,284 of 2,686 healthcare employers by filings
The ledger
| Fiscal year | Filed | Certified | Denied | Avg offered wage | Avg prevailing |
|---|---|---|---|---|---|
| FY2022 | 2 | 2 | 0 | $117,358 | $98,156 |
| FY2023 | 2 | 2 | 0 | $234,482 | $155,646 |
| FY2024 | 3 | 3 | 0 | $156,017 | $145,986 |
| FY2025 | 3 | 1 | 0 | $275,667 | $167,758 |
| FY2026 * | 2 | 2 | 0 | $173,772 | $158,704 |
What they file for
- associate director, data strategy & omnichannel enablement$179,1813
- avp, commercial excellence analytics$320,6673
- global regulatory affairs manager$118,0521
- manager, r&d$134,7151
- sr. manager, ai engineer$160,0001
- sr. manager, commercial applications$175,0001
- sr. manager, r&d$158,9631
- sr. regulatory affairs associate$100,0001
Where
- new york, ny7
- bridgewater, nj5
Every number on this page is free. Members get an email when this employer files again, a CSV of the full record, and the complete rankings with state and job-title filters.
Watch this employerGet the quarterly H-1B update, free
When DOL publishes new filings we send what changed: the biggest movers and the slimmest wage premiums. No account needed. Members also get alerts for Stemline Therapeutics, Inc. and any other employer they watch.
Certification rate 83.3%How these numbers are computed